Arrowhead Research | ARWR - Trade Debtors


Arrowhead Research reported $218.87M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Agios Pharmaceuticals USD 10.58M 5.55M Dec/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
Anika Therapeutics USD 21.99M 1.61M Mar/2025
Arrowhead Research USD 218.87M 212.05M Dec/2025
Heron Therapeutics USD 67.04M 6.9M Sep/2024
Incyte USD 1.02B 128.52M Dec/2025
Ionis Pharmaceuticals USD 66M 41.39M Dec/2025
Ligand Pharmaceuticals USD 58.1M 15.98M Sep/2025
Merck USD 12.12B 596M Sep/2025
Moderna USD 184M 862M Dec/2025
Nektar Therapeutics USD 0 2.9M Sep/2024
Novartis USD 8.98B 192M Sep/2025
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
TG Therapeutics USD 265.38M 33.86M Sep/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025
Xencor USD 29.3M 7.49M Dec/2025